Back to Article List

FDA Provides Temporary Flexibility Regarding the Egg Safety Rule During COVID-19 Pandemic While Still Ensuring the Safety of Eggs


May 04, 2020

As a result of the COVID-19 pandemic, the U.S. Food and Drug Administration today released a guidance document, Temporary Policy Regarding Enforcement of 21 CFR Part 118 (the Egg Safety Rule) During the COVID-19 Public Health Emergency to provide producers of shell eggs that normally would be sent to facilities for further processing the flexibility to sell their eggs for distribution to retail locations, such as supermarkets, when certain conditions are present. This flexibility will help egg producers meet increased demand for shell eggs by consumers at retail locations.

The FDA rule, Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation, requires producers of shell eggs that are sold to the table egg market (e.g., sold directly to consumers in retail establishments) to implement measures to prevent Salmonella Enteritidis (SE) from contaminating eggs on the farm and from further growth during storage and transportation. SE is one of the leading causes of foodborne illness from bacteria in the United States. The regulations also require shell egg producers to maintain records concerning their compliance with the rule and to register with the FDA.

For further information (in English), click on the Link

Check the full text of the documents (in English), click on the  Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox